In 2021 and 2022, G7 Finance and Health Ministers committed to expedite implementation of existing antimicrobial resistance (AMR) strategies, to take additional steps to address antibiotic market failure, create economic conditions to preserve the effectiveness of essential existing antibiotics and ensure their access, strengthen AMR research and development (R&D), and bring novel antibacterials to market that address public health needs. An initial progress report was prepared by the Global AMR R&D Hub and WHO for the G7 Finance and Health Ministers in May 2022, with a progress update requested for 2023.
13.01.2026
Job Vacancy – Research Assistant (Minijob)
The Global AMR R&D Hub Secretariat is looking for a part-time, short-term Research Assistant to support an exciting new technical project until the summer. This is an ideal opportunity for a motivated and organised student or an early-career professional looking for additional hours.
